Holen Sie sich die Stockscreener-App
1.39
1.46%
0.02
Finanzdaten der Enveric Biosciences Inc-Aktie (ENVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
3.0274
|
- | 1.8742 | 2.5189 | 2.1875 |
| Depreciation and Amortization |
1.11%
0.0368
|
0.0372 | 0.0404 | 0.04 | 0.081 |
| Operating Income/Loss |
85.37%
-3.0274
|
-1.6332 | -1.8739 | -2.519 | -2.1875 |
| Net Interest Income/Expense |
3.63%
-0.000292
|
-0.000303 | 0.000274 | -0.000132 | 0.000002 |
| Nonoperating Income/Loss |
3.63%
-0.000292
|
-0.000303 | 0.000274 | -0.000132 | 0.00257 |
| Income/Loss From Continuing Operations Before Tax |
85.36%
-3.0277
|
-1.6335 | -1.8737 | -2.5192 | -2.185 |
| Net Income/Loss |
85.36%
-3.0277
|
-1.6335 | -1.8737 | -2.5192 | -2.185 |
| Basic Average Shares |
163.98%
3.9871
|
1.5104 | 0.3132 | 2.5957 | 1.7978 |
| Diluted Average Shares |
163.98%
3.9871
|
1.5104 | 0.3132 | 2.5957 | 1.7978 |
| Basic Earnings Per Share |
29.63%
-0.76
|
-1.08 | -10.81 | -0.97 | -1.22 |
| Diluted Earnings Per Share |
29.63%
-0.76
|
-1.08 | -10.81 | -0.97 | -1.22 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):